ES472381A1 - Un procedimiento de preparacion de la forma hidratada cris- talina, llamada forma d, de la sal de sodio de un derivado oximinado del acido 7-amino-tiazolilacetamido-cefalosporani-co - Google Patents

Un procedimiento de preparacion de la forma hidratada cris- talina, llamada forma d, de la sal de sodio de un derivado oximinado del acido 7-amino-tiazolilacetamido-cefalosporani-co

Info

Publication number
ES472381A1
ES472381A1 ES472381A ES472381A ES472381A1 ES 472381 A1 ES472381 A1 ES 472381A1 ES 472381 A ES472381 A ES 472381A ES 472381 A ES472381 A ES 472381A ES 472381 A1 ES472381 A1 ES 472381A1
Authority
ES
Spain
Prior art keywords
sodium salt
preparation
crystalline form
aminothiazolylacetamido
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES472381A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES472381(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES472381A1 publication Critical patent/ES472381A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES472381A 1977-08-17 1978-08-04 Un procedimiento de preparacion de la forma hidratada cris- talina, llamada forma d, de la sal de sodio de un derivado oximinado del acido 7-amino-tiazolilacetamido-cefalosporani-co Expired ES472381A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament

Publications (1)

Publication Number Publication Date
ES472381A1 true ES472381A1 (es) 1979-03-16

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
ES472381A Expired ES472381A1 (es) 1977-08-17 1978-08-04 Un procedimiento de preparacion de la forma hidratada cris- talina, llamada forma d, de la sal de sodio de un derivado oximinado del acido 7-amino-tiazolilacetamido-cefalosporani-co

Country Status (34)

Country Link
US (1) US4224371A (en, 2012)
EP (1) EP0001024B1 (en, 2012)
JP (1) JPS5441890A (en, 2012)
AT (2) AT366049B (en, 2012)
AU (1) AU520898B2 (en, 2012)
BG (2) BG33888A3 (en, 2012)
CA (1) CA1121343A (en, 2012)
CS (2) CS207646B2 (en, 2012)
DD (1) DD137588A5 (en, 2012)
DE (1) DE2860358D1 (en, 2012)
DK (2) DK152213C (en, 2012)
EG (1) EG13520A (en, 2012)
ES (1) ES472381A1 (en, 2012)
FI (1) FI65433C (en, 2012)
FR (1) FR2400519A1 (en, 2012)
GE (2) GEP19960475B (en, 2012)
GR (1) GR73661B (en, 2012)
HR (1) HRP931395B1 (en, 2012)
HU (1) HU181497B (en, 2012)
IE (1) IE47230B1 (en, 2012)
IL (1) IL55186A (en, 2012)
IT (1) IT1107961B (en, 2012)
MD (2) MD247C2 (en, 2012)
MX (2) MX155976A (en, 2012)
NO (1) NO156168C (en, 2012)
NZ (1) NZ188163A (en, 2012)
OA (1) OA06016A (en, 2012)
PL (1) PL126619B1 (en, 2012)
PT (1) PT68431A (en, 2012)
RO (1) RO79999A (en, 2012)
SI (1) SI7811917A8 (en, 2012)
SU (2) SU799666A3 (en, 2012)
YU (1) YU42166B (en, 2012)
ZA (1) ZA784187B (en, 2012)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
EP0233255B1 (en) * 1985-08-12 1996-05-29 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
NZ188163A (en) 1981-10-19
US4224371A (en) 1980-09-23
NO156168B (no) 1987-04-27
JPS6145626B2 (en, 2012) 1986-10-08
DK163514C (da) 1992-07-27
DK152213C (da) 1988-07-11
YU42166B (en) 1988-06-30
IL55186A (en) 1981-07-31
CA1121343A (fr) 1982-04-06
PT68431A (fr) 1978-09-01
EG13520A (en) 1982-03-31
MD247B1 (ro) 1995-07-31
MD225C2 (ro) 1995-12-31
CS207646B2 (en) 1981-08-31
JPS5441890A (en) 1979-04-03
CS207647B2 (en) 1981-08-31
IT1107961B (it) 1985-12-02
FR2400519A1 (fr) 1979-03-16
PL126619B1 (en) 1983-08-31
FI65433B (fi) 1984-01-31
RO79999A (ro) 1982-10-11
GEP19960475B (en) 1996-07-22
DK159786A (da) 1986-04-09
HRP931395B1 (en) 1996-04-30
BG33887A3 (bg) 1983-05-16
OA06016A (fr) 1981-06-30
IE47230B1 (en) 1984-01-25
AT366050B (de) 1982-03-10
AT366049B (de) 1982-03-10
DD137588A5 (de) 1979-09-12
FI782494A7 (fi) 1979-02-18
MX155976A (es) 1988-06-06
ATA563578A (de) 1981-07-15
IL55186A0 (en) 1978-09-29
MD225B1 (ro) 1995-06-30
SU852175A3 (ru) 1981-07-30
HU181497B (en) 1983-07-28
IE781669L (en) 1979-02-17
DE2860358D1 (en) 1981-03-12
NO782782L (no) 1979-02-20
YU191778A (en) 1983-02-28
SU799666A3 (ru) 1981-01-23
GEP19960476B (en) 1996-07-22
NO156168C (no) 1987-08-19
PL209080A1 (pl) 1979-06-04
DK152213B (da) 1988-02-08
IT7850648A0 (it) 1978-08-08
FI65433C (fi) 1984-05-10
AU3896578A (en) 1980-02-21
DK159786D0 (da) 1986-04-09
ATA52280A (de) 1981-07-15
AU520898B2 (en) 1982-03-04
SI7811917A8 (en) 1997-12-31
EP0001024B1 (fr) 1981-01-21
BG33888A3 (bg) 1983-05-16
MX5448E (es) 1983-08-09
FR2400519B1 (en, 2012) 1980-05-16
DK361078A (da) 1979-02-18
GR73661B (en, 2012) 1984-03-28
MD247C2 (ro) 1995-12-31
ZA784187B (en) 1979-09-26
EP0001024A1 (fr) 1979-03-07
DK163514B (da) 1992-03-09

Similar Documents

Publication Publication Date Title
ES472381A1 (es) Un procedimiento de preparacion de la forma hidratada cris- talina, llamada forma d, de la sal de sodio de un derivado oximinado del acido 7-amino-tiazolilacetamido-cefalosporani-co
ES2018111A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
NL940004I1 (nl) Piperazinecarboxamide- en -carbothioamidederivatenwerkwijze ter bereiding daarvan alsmede farmaceut isch preparaat dat een dergelijk derivaat omvat
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
AR024944A1 (es) Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion
ES8606262A1 (es) Procedimiento para preparar derivados de pleuromutilina
SE422051B (sv) Alkynylcyklopropankarboxylsyraestrar till anvendning som insekticider
DE60021873D1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
ES8609343A1 (es) Un metodo para preparar un derivado de cefem
ES476917A1 (es) Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.
IL35875A0 (en) New pharmaceutical compositions for the treatment of microbial infections containing a glutamic acid derivative
SE7411243L (en, 2012)
GB1390867A (en) Quinoline derivatives
PT68275A (fr) Procede pour la preparation de vaccins contre les maladiesprovoquees par des paramixovirus
GB1289850A (en, 2012)
GB1544819A (en) Antibiotic substances derived from antibiotic 67-694(rosamicin)and processes for their preparation
DK166384C (da) Analogifremgangsmaade til fremstilling af (-)-15-deoxyspergualing og farmaceutisk acceptable syreadditionsssalte heraf samt mellemprodukt
SE7607300L (sv) Tiaxantenforeningar samt forfarande for framstellning av dem
ES478115A1 (es) Procedimiento para la preparacion de derivados acilicos.
ES8707193A1 (es) Un metodo para producir derivados de bromodicloroimidazol
SE7906509L (sv) Nya derivat av 6-metoxi-2-acetylnaftalenoxim
FR2356655A1 (fr) Derives de l'acide methoxy-7a-cephalosporanique utilises comme medicaments contre les bacteries gram-positives et gram-negatives
FR2412526A1 (fr) Composes 1-thiocyanatonaphtaleniques 8-substitues et leur utilisation comme biocides
GB1473981A (en) Hydrazino-cephalosporanic acid derivatives
BE824880A (fr) Procede de preparation de alpha-galactosidase par des micro-organismes

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 19990206